Detalhe da pesquisa
1.
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
N Engl J Med
; 384(13): 1191-1203, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33789008
2.
A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancer.
Invest New Drugs
; 42(2): 221-228, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38441850
3.
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform.
Oncologist
; 28(6): 553-e472, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36940261
4.
Hyperpolarized 13 C Metabolic MRI of Patients with Pancreatic Ductal Adenocarcinoma.
J Magn Reson Imaging
; 2023 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041836
5.
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(7): 753-782, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433437
6.
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study.
Lancet Oncol
; 22(1): 118-131, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387490
7.
Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma.
Oncologist
; 26(11): e1982-e1991, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34506673
8.
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(4): 439-457, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33845462
9.
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer.
Mol Ther
; 28(11): 2367-2378, 2020 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730744
10.
Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer.
Oncologist
; 25(7): 564-571, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32031306
11.
Estimation of Fractional Extracellular Space at CT for Predicting Chemotherapy Response and Survival in Pancreatic Ductal Adenocarcinoma.
AJR Am J Roentgenol
; 215(3): 610-616, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32755156
12.
Pancreatic Adenocarcinoma, Version 1.2019.
J Natl Compr Canc Netw
; 17(3): 202-210, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865919
13.
Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI.
AJR Am J Roentgenol
; 211(5): 1010-1019, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30063366
14.
A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS.
Oncologist
; 22(9): 1024-e89, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28592615
15.
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial.
Oncologist
; 22(12): 1427-e129, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935773
16.
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(8): 1028-1061, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28784865
17.
A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies.
Breast Cancer Res Treat
; 155(3): 521-30, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26875185
18.
A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers.
Invest New Drugs
; 34(3): 319-28, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26994014
19.
Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?
J Surg Oncol
; 114(5): 587-596, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27444658
20.
Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity.
J Surg Oncol
; 114(7): 838-847, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27569043